Search Results - "VON LUBITZ, D. K. J. E"

Refine Results
  1. 1

    Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A 1 receptor agonist by Von Lubitz, Dag K.J.E, Lin, Rick C.-S, Bischofberger, Norbert, Beenhakker, Mark, Boyd, Mellonie, Lipartowska, Renata, Jacobson, Kenneth A

    Published in European journal of pharmacology (1999)
    “…Although the selectivity and potency of adenosine amine congener (ADAC) at adenosine A 1 receptors are similar to other highly selective agonists at this…”
    Get full text
    Journal Article
  2. 2

    Adenosine A3 receptor stimulation and cerebral ischemia by Von Lubitz, D K, Lin, R C, Popik, P, Carter, M F, Jacobson, K A

    Published in European journal of pharmacology (22-09-1994)
    “…Chronic treatment with the selective adenosine A3 receptor agonist N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide (IB-MECA) administered prior to either 10…”
    Get more information
    Journal Article
  3. 3

    Cerebral ischemia in gerbils : effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist by VON LUBITZ, D. K. J. E, LIN, R. C. S, JACOBSON, K. A

    Published in European journal of pharmacology (20-12-1995)
    “…Despite significant progress in understanding of the potential of adenosine A1 receptor-based therapies in treatment of cerebral ischemia and stroke, very…”
    Get full text
    Journal Article
  4. 4

    Adenosine and cerebral ischemia: therapeutic future or death of a brave concept? by Von Lubitz, Dag K.J.E.

    Published in European Journal of Pharmacology (15-01-1999)
    “…Numerous studies have consistently shown that agonist stimulation of adenosine A 1 receptors results in a significant reduction of morbidity and mortality…”
    Get full text
    Book Review Journal Article
  5. 5

    Chronic administration of adenosine A3 receptor agonist and cerebral ischemia : neuronal and glial effects by VON LUBITZ, D. K. J. E, LIN, R. C.-S, BOYD, M, BISCHOFBERGER, N, JACOBSON, K. A

    Published in European journal of pharmacology (19-02-1999)
    “…We have previously shown that chronic administration of the selective A3 receptor agonist N6-(3-iodobenzyl)-5'-N-methylcarboxoamidoadenosine (IB-MECA) leads to…”
    Get full text
    Journal Article
  6. 6

    Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist by VON LUBITZ, D. K. J. E, LIN, R. C.-S, BISCHOFBERGER, N, BEENHAKKER, M, BOYD, M, LIPARTOWSKA, R, JACOBSON, K. A

    Published in European journal of pharmacology (26-03-1999)
    “…Although the selectivity and potency of adenosine amine congener (ADAC) at adenosine A1 receptors are similar to other highly selective agonists at this…”
    Get full text
    Journal Article
  7. 7

    The effects of adenosine A3 receptor stimulation on seizures in mice by VON LUBITZ, D. K. J. E, CARTER, M. F, DEUTSCH, S. I, LIN, R. C.-S, MASTROPAOLO, J, MESHULAM, Y, JACOBSON, K. A

    Published in European journal of pharmacology (24-02-1995)
    “…We have previously shown that acute preischemic adenosine A3 receptor stimulation results in an increased postischemic damage, while chronic stimulation of…”
    Get full text
    Journal Article
  8. 8

    Chronic administration of selective adenosine A1 receptor agonist or antagonist in cerebral ischemia by Von Lubitz, D K, Lin, R C, Melman, N, Ji, X D, Carter, M F, Jacobson, K A

    Published in European journal of pharmacology (21-04-1994)
    “…The effect of chronic administration of selective adenosine A1 receptor agonists and antagonists on the outcome of cerebral ischemia is entirely unknown…”
    Get more information
    Journal Article
  9. 9

    Effects of chronic administration of adenosine A1 receptor agonist and antagonist on spatial learning and memory by Von Lubitz, D K, Paul, I A, Bartus, R T, Jacobson, K A

    Published in European journal of pharmacology (16-11-1993)
    “…Spatial memory acquisition in Morris water maze was tested in C57BL/6 mice. Animals were injected once daily with different doses of either…”
    Get more information
    Journal Article
  10. 10

    Internucleosomal DNA fragmentation in gerbil hippocampus following forebrain ischemia by Sei, Y, Von Lubitz, K J, Basile, A S, Borner, M M, Lin, R C, Skolnick, P, Fossom, L H

    Published in Neuroscience letters (25-04-1994)
    “…Internucleosomal DNA fragmentation, the characteristics feature of programmed cell death, was demonstrated in gerbil hippocampus following 10 min of forebrain…”
    Get more information
    Journal Article
  11. 11

    Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A1 receptor agonist by VON LUBITZ, D. K. J. E, BEENHAKKER, M, LIN, R. C.-S, CARTER, M. F, PAUL, I. A, BISCHOFBERGER, N, JACOBSON, K. A

    Published in European journal of pharmacology (29-04-1996)
    “…Agonists of adenosine A1 receptors have been frequently proposed as candidates for clinical development in treatment of cerebral ischemia and stroke. Numerous…”
    Get full text
    Journal Article
  12. 12

    Chronic adenosine A1 receptor agonist and antagonist: effect on receptor density and N-methyl-D-aspartate induced seizures in mice by Von Lubitz, D K, Paul, I A, Ji, X D, Carter, M, Jacobson, K A

    Published in European journal of pharmacology (21-02-1994)
    “…The effect of chronic administration of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) and the adenosine A1 antagonist…”
    Get more information
    Journal Article
  13. 13

    Postischemic administration of adenosine amine congener (ADAC): analysis of recovery in gerbils by Von Lubitz, Dag K.J.E., Lin, Rick C.-S., Paul, Ian A., Beenhakker, Mark, Boyd, Mellonie, Bischofberger, Norbert, Jacobson, Kenneth A.

    Published in European journal of pharmacology (05-12-1996)
    “…Although adenosine receptor-based treatment of cerebral ischemia and other neurodegenerative disorders has been frequently advocated, cardiovascular side…”
    Get full text
    Journal Article
  14. 14
  15. 15

    A novel treatment of global cerebral ischaemia with a glycine partial agonist by Von Lubitz, D K, Lin, R C, McKenzie, R J, Devlin, T M, McCabe, R T, Skolnick, P

    Published in European journal of pharmacology (14-08-1992)
    “…Chronic treatment of gerbils with 1-aminocyclopropanecarboxylic acid (a high affinity, partial agonist at strychnine-insensitive glycine receptors) resulted in…”
    Get more information
    Journal Article
  16. 16

    Adenosine A3 receptor agonist-induced neurotoxicity in rat cerebellar granule neurons by Sei, Yoshitatsu, Lubitz, Dag K.J.E. von, Abbracchio, Maria P., Ji, Xiao-duo, Jacobson, Kenneth A.

    Published in Drug development research (01-03-1997)
    “…Acute stimulation of A3 adenosine receptors has been shown to intensify damage in an in vivo model of global cerebral ischemia and to induce cell death in cell…”
    Get full text
    Journal Article
  17. 17

    Chronic NMDA receptor stimulation : therapeutic implications of its effect on adenosine A1 receptors by VON LUBITZ, D. K. J. E, KIM, J, BEENHAKKER, M, CARTER, M. F, LIN, R. C.-S, MESHULAM, Y, DALY, J. W, SHI, D, ZHOU, L.-M, JACOBSON, K. A

    Published in European journal of pharmacology (05-09-1995)
    “…It is known that stimulation of adenosine A1 receptors has a modulatory effect on the excitability of postsynaptic NMDA receptors. Conversely, acute…”
    Get full text
    Journal Article
  18. 18

    Effects of N6-cyclopentyl adenosine and 8-cyclopentyl-1,3-dipropylxanthine on N-methyl-D-aspartate induced seizures in mice by Von Lubitz, D K, Paul, I A, Carter, M, Jacobson, K A

    Published in European journal of pharmacology (16-11-1993)
    “…The effect of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) and antagonist 8-cyclopentyl-1,3-dipropylxanthine (CPX) on N-methyl-D-aspartate…”
    Get more information
    Journal Article
  19. 19

    MK-801 is neuroprotective but does not improve survival in severe forebrain ischemia by Von Lubitz, D K, McKenzie, R J, Lin, R C, Devlin, T M, Skolnick, P

    Published in European journal of pharmacology (16-03-1993)
    “…The effects of MK-801 on postischemic recovery, survival and neuronal preservation in the cortex, hippocampus and striatum were studied in Mongolian gerbils…”
    Get more information
    Journal Article
  20. 20

    Neuroprotective activity of dimer of 16,16'-dimethyl-15-dehydroprostaglandin B1 (di-Calciphor) in cerebral ischemia by Lin, R C, Matesic, D F, McKenzie, R J, Devlin, T M, von Lubitz, D K

    Published in Brain research (19-03-1993)
    “…Post-ischemic treatment of di-Calciphor (16,16'-dimethyl-15- dehydroprostaglandin B1) significantly improves animal survival and prevents ischemia-induced…”
    Get more information
    Journal Article